Silver Book Fact

An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment and caregiver-support programs; the greatest benefits with a combination of both.

Weimer D, Sager M. Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes. Alzheimers Dement. 2009; 5(3): 215-26. https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1016/j.jalz.2009.01.028

Reference

Title
Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes
Publication
Alzheimers Dement
Publication Date
2009
Authors
Weimer D, Sager M
Volume & Issue
Volume 5, Issue 3
Pages
215-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s
     
  • Out-of-Pocket Costs, 5-Year Delayed Onset  
  • Medicare Costs, 5-Year Delayed Onset  
  • Valuing a QALY at $175,000, new drugs that would produce a 5-year delay in Alzheimer’s disease onset for all new cases between 2010 and 2050 would yield a benefit of…  
  • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.